Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 71.62 Delayed Data As of May 23 |  +0.48 / +0.67%Today’s Change | 61.28 Today|||52-Week Range 101.24 | -20.47% Year-to-Date |
Latest SRPT News | Press Releases
| Moderna CEO: Our Technology Has the Opportunity to Change Medicine May 18 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 71.13 |
| Today’s open | 71.70 |
| Day’s range | 70.87 - 73.18 |
| Volume | 1,059,134 |
| Average volume (3 months) | 853,343 |
| Market cap | $6.1B |
Data as of 4:00pm ET, 05/23/2022
Growth & Valuation
| Earnings growth (last year) | +27.50% |
| Earnings growth (this year) | +9.94% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +29.96% |
| P/E ratio | NM |
| Price/Sales | 10.43 |
| Price/Book | 6.50 |
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$1.11 |
| Annual revenue (last year) | $701.9M |
| Annual profit (last year) | -$418.8M |
| Net profit margin | -59.66% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
